EyePoint (EYPT) Interest Coverage Ratio (2018 - 2024)
EyePoint (EYPT) posted Interest Coverage Ratio of 2.65 for Q1 2026, down 110.06% sequentially from 26.38 in Q4 2025, and up 81.13% YoY from 1.47 in Q1 2025.
Powered by 
Analysis
EyePoint (EYPT) Interest Coverage Ratio (2018 - 2024) Analysis & Trends
EyePoint has reported Interest Coverage Ratio for 16 years, with the latest figure at 2.65 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 81.13% year-over-year to 2.65 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8.57 (up 81.55% YoY) and the FY2025 annual result came in at 3.33, up 82.94% from the prior year.
- Interest Coverage Ratio fell to 2.65 in Q1 2026 per EYPT's latest filing, from 26.38 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 26.38 in Q4 2025 and troughed at 64.63 in Q4 2024.
- A 5-year average of 11.39 and a median of 1.38 in 2023 frame the typical range for Interest Coverage Ratio.
- The widest YoY moves for Interest Coverage Ratio: up 140.81% in 2025, down 2632.11% in 2025.
- Over 5 years, Interest Coverage Ratio stood at 63.11 in 2022, then surged by 59.95% to 25.28 in 2023, then slumped by 155.68% to 64.63 in 2024, then jumped by 140.81% to 26.38 in 2025, then sank by 110.06% to 2.65 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 2.65, 26.38, and 1.36 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | EyePoint | 398.53 Mn | 218.06 Mn | 507,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -3,231.36 |
| Jun 30, 2023 | -52.32 |
| Mar 31, 2023 | -26.54 |
| Dec 31, 2022 | -56.00 |
| Sep 30, 2022 | -27.79 |
| Jun 30, 2022 | -34.81 |
| Mar 31, 2022 | -15.31 |
| Dec 31, 2021 | -13.00 |
| Sep 30, 2021 | -11.03 |
| Jun 30, 2021 | -7.98 |
| Mar 31, 2021 | -8.12 |
| Dec 31, 2020 | -6.97 |
| Sep 30, 2020 | -1.06 |
| Jun 30, 2020 | -6.17 |
| Mar 31, 2020 | -6.41 |
| Dec 31, 2019 | -5.03 |
| Sep 30, 2019 | -7.94 |
| Jun 30, 2019 | -6.36 |
| Mar 31, 2019 | -14.36 |
| Dec 31, 2018 | -14.96 |